Anthropic CEO Dario Amodei believes artificial intelligence could help humanity overcome some of its most difficult medical challenges within the next decade, including cancer, Alzheimer’s disease, heart disease and mental illness.
In an investor presentation released ahead of the company’s planned initial public offering, Amodei predicted that these conditions could become “relics of the past” in less than 10 years.
“If today we look at things like cancer, Alzheimer’s, heart disease and mental illness, these will be relics of the past in, I think, less than a decade,” he said.
The statement reflects Amodei’s belief that advances in AI could significantly accelerate biological research, drug discovery and medical development. However, it is a prediction about the technology’s potential, not a scientific finding that these diseases are close to being cured.
How Anthropic plans to use AI in medical research
Anthropic has been expanding beyond general-purpose AI models into drug discovery and biological research. In October, the company disclosed that it had started its own drug discovery efforts and was working with several organisations in the pharmaceutical and biotechnology industries.
It also acquired Mithril Medicine, a small biotechnology company that used Claude to coordinate research activities across external laboratories. The project has been investigating a potential treatment for a rare muscle-wasting disease. According to Anthropic, early experiments in mice showed improvements in muscle strength among treated animals.
The research remains at the preclinical stage. It has not yet been established that the potential treatment is safe or effective in humans. Anthropic is also exploring how AI can support biological research through laboratory work and partnerships with pharmaceutical companies.
Amodei believes these applications could help researchers identify promising drug candidates, analyse biological data and accelerate parts of the development process that traditionally take years.
Medical experts question the 10-year timeline
Despite the possibilities AI presents, Amodei’s prediction has attracted criticism from medical professionals and researchers who consider the timeline unrealistic.
Karl Lauterbach, Germany’s former health minister, said AI could contribute to treating cancer, Alzheimer’s and mental illness but questioned whether these conditions could be overcome within 10 years.
AI medical researcher Melinda B. Chu also questioned Anthropic’s ability to make a meaningful contribution to such outcomes, while biotechnology executive Rami Elghandour criticised the prediction as inappropriate for an IPO presentation.
AI also cannot simply eliminate scientific challenges. Cancer, for example, is not one disease but a broad group of conditions with different causes, behaviours and treatment responses. Alzheimer’s disease and heart disease also involve complex biological processes that require extensive research and testing.
Even when AI helps researchers identify a promising drug, that candidate must still undergo laboratory testing, clinical trials and regulatory review before it can be made available to patients. AI could shorten some stages of this process, but it cannot establish a treatment’s safety and effectiveness without evidence from real-world biological testing.
AI’s medical potential faces a major test
Amodei’s prediction comes as leading AI companies increasingly position healthcare and drug discovery as important areas for their technology.
For Anthropic, the opportunity extends beyond developing Claude as a chatbot or coding assistant. The company wants its models to support scientific research and potentially accelerate the development of treatments for diseases that have challenged medicine for decades.
However, the gap between identifying a possible treatment and delivering an approved cure remains significant. Whether AI can make major diseases far easier to prevent and treat within the next decade will depend on research results, clinical trials, and regulatory approval. For now, Amodei’s statement is an ambitious forecast of what AI might achieve, not evidence that cancer, Alzheimer’s, heart disease or mental illness will disappear by 2036.
Read also: Binance warns iPhone users of flaw that could expose crypto wallet keys